Search

everythinglearnresearchcommunity

for

Search:↓

Topical rapamycin may effectively treat fibrous papules on the face.

mTOR inhibitors may help treat lung fibrosis.

A protein complex called mTORC1 likely affects when hair growth starts in mice.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

EGFR and mTOR inhibitors may help manage Olmsted syndrome symptoms.

Eating a high-glycemic diet may worsen acne by increasing certain protein levels and expressions in the skin.

mTOR may link different pathways in hair follicle tumor formation.

mTORC2 is crucial for healthy skin barrier by regulating lipids and filaggrin.

Rapamycin may help treat Leigh syndrome by targeting protein kinase C.

Cow milk sugars increase fat production and inflammation in skin oil cells.

Dihydrotestosterone (DHT) doesn't affect rat skin cell growth, but it does change cell cycle, protein levels, and other cell functions, potentially shortening hair growth cycle.

Human sebaceous glands contain enzymes that affect androgen production and may influence sebum production and acne.

Metformin, usually used for diabetes, can also help treat hair loss from alopecia areata due to its ability to reduce inflammation and stimulate new hair growth.

The cause of Frontal fibrosing alopecia, a type of hair loss, is complex, likely involving immune responses and genetics, but is not fully understood.

Rapamycin treatment helps with mitochondrial disease by reducing PKC levels.

Sesn2 protects inner ear hair cells from damage by regulating certain cell survival pathways.

The study found that analyzing certain cell signaling pathways is not a reliable method to tell apart two types of skin tumors.

Targeting glycolysis may help treat PCOS by improving insulin sensitivity and ovarian function.

Transplant patients on immunosuppressive medications have a higher risk of skin cancer, and managing this involves balancing medication with cancer risk.

Skin problems from transplant drugs are common and need careful management in organ transplant patients.

Misbehaving hair follicle stem cells can cause hair loss and offer new treatment options.

Certain inhibitors slow down plant growth by causing early cell specialization without changing the cell development pattern.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

A molecule called α-ketobutyrate was found to extend lifespan and improve aging-related symptoms in worms and mice by activating certain cellular pathways and may help develop anti-aging treatments for humans.

Disrupting the Flcn gene in mice causes early kidney cysts and tumors, which can be treated with rapamycin.

The document concludes that understanding genetic mutations in the PI3K-AKT-mTOR pathway can lead to better diagnosis and treatment for certain genetic skin disorders.

New therapies for Birt–Hogg–Dubé syndrome are being developed based on understanding the FLCN gene's role.

Certain small molecules can promote hair growth by activating a cellular cleanup process called autophagy.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

Studying premature aging syndromes helps understand human aging and suggests potential treatments.